Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vebicorvir - Assembly Biosciences

Next Previous
X
Search
Drug Profile

Vebicorvir - Assembly Biosciences

Alternative Names: ABI-H0731; VBR

Latest Information Update: 08 Mar 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Indiana University
  • Developer Antios Therapeutics; Assembly Biosciences
  • Class Amides; Antivirals; Small molecules; Thiazepines; Thiazoles
  • Mechanism of Action Viral core protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Hepatitis B

Most Recent Events

  • 31 Dec 2023 BeiGene receives a termination notice from Assembly Biosciences for License and Collaboration Agreement in China for development and commercialisation of ABI H0731, ABI H2158, and ABI H3733
  • 10 Nov 2023 Efficacy and adverse events data from phase-IIa trial in Hepatitis-B presented at the 74th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2023)
  • 06 Oct 2023 Assembly Biosciences terminates a phase-II clinical trial in Hepatitis B (Combination therapy) in China (PO) by the study Sponsor for strategic reasons to prioritize research and development efforts on finite and curative HBV therapies (NCT04781647)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top